Skip to main content

Full text of "USPTO Patents Application 10597633"

See other formats


(- 



PATENT COOPERATION TREATY 



From the 

INTERNATIONAL PRELIMINARY EXAMINING AUTHORITY 



To: 

FENSTER, Paul et al. 
FENSTER & COMPANY 
INTELLECTUAL PROPERTY LTD. 



I . w , 



IL-49002 Petach Tikva 
ISRAEL 



PCT 



NOTIFICATION OF TRANSMITTAL OF 
THE INTERNATIONAL PRELIMINARY 
REPORT ON PATENTABILITY 

(PCT Rule 71.1) 



Date of mailing 
(dayfrnonth/year) 



12.06.2006 



Applicant's or agent's file reference 
41 4v04493 


IMPORTANT NOTIFICATION 


International application No. 
• PCT/IL2Q05/000442 


International filing date (dayAnonth/year) 
28.04.2005 


Priority date (day/monthfyear) 
29.04.2004 


Applicant 

REABILtTY INC. et a!. 



1 , The applicant is hereby notified that this International Preliminary Examining Authority transmits herewith the 
international preliminary report on patentability and its annexes, if any, established on the international 
application, 

2. A copy of the report and its annexes, if any, is being transmitted to the international Bureau for 
communication to al! the elected Offices. 

3 where required by any of the elected Offices, the International Bureau will prepare an English translation of 
the report {but not of any annexes) and wiii transmit such translation to those Offices. 

4. REMINDER 

The applicant must enter the national phase before each elected Office by performing certain acts (filing 
translations and paying national fees) within 30 months from the priority date (or later in some Offices) 
(Article 39(1)) (see also the reminder sent by the international Bureau with Form PCT/IB/S01 ). 

Where a translation of the international application must be furnished to an elected Office, that translation 
must contain a translation of any annexes to the international preliminary report on patentability. It is the 
applicant's responsibility to prepare and furnish such translation directly to each elected Office concerned. 

For further details on the applicable time limits and requirements of the elected Offices, see Volume II of the 
PCT Applicant's Guide. 

The applicant's attention is drawn to Article 33(5), which provides that the criteria of novelty, inventive step 
and industrial applicability described in Article 33(2) to (4) merely serve the purposes of international 
preliminary examination and that "any Contracting State may apply additional or different criteria for the 
purposes of deciding whether, in that State, the claimed inventions is patentable or not" (see also Article 
27(5)). Such additional criteria may relate, for example, to exemptions from patentability, requirements for 
enabling disclosure, clarity and support for the claims. 





Name and mailing address of the international 
preliminary examining authority: 




European Patent Office 
D-80298 Munich 

Tel +49 89 2399 - 0 Tx: 523656 epmu d 
Fax: +49 89 2399 - 4465 



Authorized Officer 

Ullrich, C 

Tel. +49 89 2399-232P 



Form PCT/1PEA/416 {January 2004) 



RFTPIVFft 

Us SLt. a w sLa £L# 



Docketed By_ 



18 



to: 






JBMMmi IB 



ft i </f 



PENSTER 



PATENT COOPERATION TREATY 






INTERNATIONAL PRELIMINARY REPORT ON PATENTABILITY 

(Chapter II of the Patent Cooperation Treaty) 

(PCT Article 36 and Rule 70) 



Applicant's or agent's file reference 
414£)4493 



international application No. 
PCT/IL2 00 5/300442 



FOR FURTHER ACTION 



See Form PCT/1 PEA/41 6 



International filing date (day/monihfyear) 
28.04.2005 



Priority date (dayAnonth/year) 
29.04.2004 



International Patent Classification (IPC) or national classification and IPC 
INV. A61N1/36 A61B5/11 A61 B5£)488 A61 H1J02 



Applicant 

REABILITY INC. et al. 



1 . This report is the international preliminary examination report, established by this. International Preliminary Examining 
Authority under Article 35 and transmitted to the applicant according to Article 36. 

2. This REPORT consists of a total of 8 sheets, including this cover sheet. 

3. This report is also accompanied by ANNEXES, comprising: 

a. M sent to the applicant and to the international Bureau) a total of 4 sheets, as follows: 

E3 sheets of the description, claims and/br drawings which have been amended and are the basis of this report 
and/or sheets containing rectifications authorized by this Authority (see Rule 70.16 and Section 607 of the 
Administrative Instructions). 

□ sheets which supersede earlier sheets, but which this Authority considers contain an amendment that goes 
beyond the disclosure in the international application as filed, as indicated in item 4 of Box No. I and the 
Supplemental Box. 

b □ (sent to the Internationa} Bureau onfy) a total of (indicate type and number of electronic carrier(s)) , containing a 
sequence listing and/or tables related thereto, in electronic form only, as indicated in the Supplemental Box 
Roiatinn tn RftQiiAnr.P I tetina feee Section 802 of the Administrative Instructions). 



4. This report contains indications relating to the following items: 





Box No. 


I 


Basis of the report 


□ 


Box No. 


II 


Priority 




Box No. 


ill 


Non-establishment of opinion with regard to novelty, inventive step and industrial applicability 


□ 


Box No. 


IV 


Lack of unity of invention 




Box No. 


V 


Reasoned statement under Article 35(2) with regard to novelty, inventive step or industrial 
applicability; citations and explanations supporting such statement 


la 


Box No. 


VI 


Certain documents cited 




Box No. 


VI! 


Certain defects in the international application 


□ 


Box No. 


Vill 


Certain observations on tfee international application 



Date of submission of the demand 
28.02.2006 


Date of completion of this report 
12.06.2006 


Name and maHing address of the international 
preliminary examining authority: 

— European Patent Office 

3& D-80298 Munich 
Jf/ Tel. +49 89 2399 - 0 Tx: 523656 epmu d 


Authorized officer 

Fischer, O I f 

Telephone No, +49 89 2399-2327 



Form PCT/IPEA/409 (Cover Sheet) (April 2005) 



INTERNATIONAL PRELIMINARY REPORT 
ON PATENTABILITY 



International application No. 
PCT/lL2005y000442 



Box No, I Basis of the report 

1 . With regard to the language, this report is based on 

B the international application in the language m which it was filed 

□ a translation of the international application into , which is the language 
of a translation furnished for the purposes of: 

□ international search (under Rules 12.3(a) and 23.1(b)) 

□ publication of the international application (under Rule 12.4(a)) 

□ international preliminary examination (under Rules 55.2(a) and/or 55.3(a)) 

2. With regard to the elements* of the international application, this report is based on (replacement sheets which 
have been furnished to the receiving Office in response to an invitation under Article 14 are referred to in this 
report as "originally filed" and are not annexed to this report): 



Description, Pages 

1 -32 as originally filed 

Claims, Numbers 

1 -31 filed with telefax on 28.02.2006 

Drawings, Sheets 

1 u-i 77 as originally filed 

□ a sequence listing and/or any related tabie(s) - see Supplemental Box Relating to Sequence Listing 

3. □ The amendments have resulted in the cancellation of: 

□ the description, pages 

□ the claims, Nos. 

□ the drawings, sheets/figs 

□ the sequence listing (specify): 

□ any table(s) related to sequence listing (specify): 

4. □ This report has been established as if (some of) the amendments annexed to this- report and fisted below 
had not been made, since they have been considered to go beyond the disclosure as filed, as indicated in the 
Supplemental Box (Rule 70.2(c)). 

□ the description, pages 

□ the claims, Nos. 

□ the drawings, sheets/figs 

□ the sequence listing (specify): 

□ any table(s) related to sequence listing (specify): 

* If item 4 applies, some or all of these sheets may be marked "superseded. " 



Form PCT/iPEA/ 409 (April 2005) 



INTERNATIONAL PRELIMINARY REPORT International application No. 

ON PATENTABILITY PCT/1L2005/000442 



Box No. Ill Mon-establishment of opinion with regard to novelty, inventive step and industrial 
applicability 

i . The questions whether the claimed invention appears to be novel, to involve an inventive step {to be non- 
obvious), or to be industrially applicable have not been examined in respect of: 

□ the entire international application, 
M claims Nos. 31 

because: 

E3 the said international application, or the said claims Nos, 3.1 relate to the following subject matter which 
does not require an international preliminary examination (specify): 

see separate sheet 

□ the description, claims or drawings (indicate particular elements below) or said claims Nos. are so unclear 
that, no meaningful opinion could be formed (specify); 

□ the claims, or said claims Nos. are so inadequately supported by the description that no meaningful opinion 
could be formed (specify). 

M no international search report has been established for the said claims Nos. 31 

□ a meaningful opinion could not be formed without the sequence listing; the applicant did not, within the 
prescribed time limit: 

□ furnish a sequence listing on paper complying with the standard provided for in Annex C of the 
Administrative Instructions, and such listing was not available to the International Preliminary 
Examining Authority in a form and manner acceptable to it. 

□ furnish a seauence iistinq in electronic form complying with the standard provided for in Annex C 
of the Administrative SnstTuctions, and such listing was not available to the Internationa! Preliminary 
Examining Authority in a form and manner acceptable to it. 

□ pay the required late furnishing fee for the furnishing of a sequence listing in response to an 
invitation under Rules 13ter.1(a) or (b) and 13fer.2. 

□ a meaningful opinion could not be formed without the tables related to the sequence listings; the applicant 
did not, within the prescribed time limit, furnish such tables in electronic form complying with the technical 
requirements provided for in Annex G-bis of the Administrative Instructions, and such tables were not 
available to the International Preliminary Examining Authority in a form and manner acceptable to it. 

□ the tables related to the nucleotide and/or amino acid sequence listing, if in electronic form only, do not 
comply with the technical requirements provided for in Annex C-bis of the Administrative Instructions. 

□ See separate sheet for further details 



Form PCT/IPEA/ 409 (April .2005) 



INTERNATIONAL PRELIMINARY REPORT international application No. 

ON PATENTABILITY PCT/1L200 5^)00442 



Box No, V Reasoned statement under Article 35(2) with regard to novelty, inventive step or industrial 
applicability; citations and explanations supporting such statement 

1. Statement 



Novelty (N) Yes: Claims 

No: Claims 1-7,11-13,15-18,20,26,27,29 



Inventive step (IS) Yes: Claims 

No: Claims 8-10,14,19,21-25,28,30 

Industrial applicability (I A) Yes: Claims 1-30 

No: Claims 



2. Citations and explanations (Rule 70.7): 
see separate sheet 



Box No. VI Certain documents cited 

1. Certain published documents (Rule 70.10) 
and /or 

2. Non-written disclosures (Rule 70.9) 
see separate sheet 



Box No. VII Certain defects in the international application 

The following defects in the form or contents of the international application have been noted: 
see separate sheet 



Form PCT/1PEA/409 {April 2005) 



INTERNATIONAL PRELIMINARY 
REPORT ON PATENTABILITY 
(SEPARATE SHEET) 



International application No. 
PCT/IL2005/000442 



Re item liL 

No search has ben carried out (Rule 39.1 (iv) PCT) for claim 31 , since it relates to a method 
for treatment of the human or animal body by therapy. Indeed, claim 31 pertains to the 
delivery of a therapeutic neuromuscular stimulation signal to the human body. Consequently, 
no opinion will be formulated with respect to the subject-matter of this claim (Article 34(4)(a)(i) 
PCT). 

Re Item V, 

1 . Reference is made to the following documents: 

D1 : WO 02/092164 A (FONDATiON SUISSE POUR LES CYBERTHESES; 
. BRODARD, ROLAND; CLAVEL, REYMON) 21 November 2002 
D2 : US 5 466 21 3 A (HOGAN ET AL) 1 4 November 1 995 
D3 : US 4 499 900 A (PETROFSKY ET AL) 1 9 February 1 985 
D4 : US 4 724 842 A (CHARTERS ET AL) 1 6 February 1 988 

2. The present application does not meet the criteria of Article 33(1) PCT, because the 
subject-matter of claim 1 is not new in the sense of Article 33(2) RCT. 

2.1 Preliminary remark 

it is pointed out that the features of the "mechanical motion element coupled to at least 
one of said body portion and a mirror body portion " and the IJ EMG sensor coupled 
to said mirror body portion " only indicates the suitability of the respective parts of the 
apparatus to be coupled to the body: in fact, they rather define the use of the apparatus 
rather than clearly defining the apparatus in terms of its technical features. The features 
emphasised in bold do therefore not limit the scope of claim 1 (Article 6 PCT). 

2.2 Document D1 (see in particular figs, 1-4) discloses (the references in parentheses 
applying to this document) an apparatus for muscle activation comprising; 

- at least one electrode (37, 38) adapted to deliver a neuromuscular stimulation signal 
to a body portion; 



Form PCT/Separate Sheet/409 (Sheet 1) (EPO-Aprii 2005} 



INTERNATIONAL PRELIMINARY 
REPORT ON PATENTABILITY 
(SEPARATE SHEET) 



international application No. 
PCT/IL2005/000442 



- at least one controller (31) adapted to provide a NMES signal comprising a sequence 
of stimulation signals to said at ieast one electrode; and 

- a mechanical motion element (2, 3, 4, 6, 7, 8, 20, 21, 22) suitable (adapted) to be 
coupled to at least one of said body portion and a mirror body portion, 

- wherein said mechanical motion element is operatively coupled to said at least one 
controller (see fig. 4) and wherein said at least one controller controls said NMES signal 
in conjunction with said mechanical motion element (p. 12, 2nd paragraph and p. 21, 
second and third paragraphs). 

Further, as becomes apparent from p. 19, I. 13-15 and L 30-32, a feedback control 
based on the muscular activity controller is implemented in the controller of D1 : indeed, 
D1 discloses the use of muscular model established by analysing the EMG signal of a 
mirror body portion (see p. 19, L 30-32). Hence, at least one EMG sensor is disclosed 
by D1 and the EMG sensor is certainly adapted to be coupled to a mirror body 
portion. 

D1 clearly discloses the "double feedback" as claimed in claim 1 (i.e. mechanical motion 
feedback and EMG feedback) (see p. 21, I. 15-28: Closed-Loop Electrical Muscle 
Stimulation). 

Accordingly, all the features of claim 1 are anticipated by D1 and claim 1 therefore lacks 
novelty (Article 33 (2) PCT). 

2.3 Further, D2 (see in particular col. 3, L 3-7; col, 6, L 54-59; fig. 14) also anticipates the 
subject-matter of claim 1, since it discloses an apparatus for muscle activation 
comprising: 

- at least one electrode (E1 or E2) adapted to deliver a neuromuscular stimulation signal 
to a body portion; 

- at least one controller (AB, 32) adapted to provide a NMES signal comprising a 
sequence of stimulation signals to said at least one electrode; and 

- a mechanical motion element (10) suitable to be coupled to at ieast one of said body 
portion and a mirror body portion, 

- wherein said mechanical motion element is operatively coupled to said at least one 
controller and wherein said at least one controller controls said NMES signal in 
conjunction with said mechanical motion element (col, 6, I. 54-59). 



Form PCT/Separate Sheet/409 (Sheet 2) (EPO-Aprii 2005) 



INTERNATIONAL PRELIMINARY 
REPORT ON PATENTABILITY 
(SEPARATE SHEET) 



International application No. 
PCT/IL2005/000442 



D2 (col. 3, I. 3-7) discloses also an EMG sensor used in combination with an NMES 
stimulator ("'Electromyographic implementation: feature and a Functional Electric 
Stimulation implementation feature). 

3. Dependent claims 2-30 do not contain any features which, in combination with the 
features of any claim to which they refer, meet the requirements of the PCT in respect 
of novelty and/or inventive step, the reasons being as follows; 

3.1 D1 anticipates the subject-matter of following claims (Article 33 (2) PCT): 

- Claims 1 -5: in D1 , the mechanical motion element moves, guides and measures motion 
of the body portion (first leg) and the mirror body portion (second leg), which motion is 
in response to said NMES sequence. 

- Claim 6: the controller of D1 is programmable, so a programmer is implicitly disclosed 
inD1. 

- Claim 7: in D1 , a closed loop feedback control for booth the mechanical motion and the 
EMG controlled stimulation is effected: hence a sequence optimisation is also disclosed. 

- Claims 11-13: see D1 , p. 21, second and third paragraphs. 

- Claim 1 5: see memory (39) of D1 . 

- Claims 1 6-18: in D1 , the operator can modify the stimulation sequence as desired (see 
p. 19, 4th paragraph - p. 20, 3rd paragraph). 

- Claim 20: force sensor (35) in D1 . 

- Claim 26: in D1, one can choose from stimulation only, stimulation assisted 
rehabilitation and "mechanical" rehabilitation only (see p. 21, last paragraph - p. 23, 3rd 
paragraph): therefore, the controller can act independently of the mechanical motion 
element. 

- Claim 27: in D1 , the electrodes are placed on the thighs and on the tegs (see fig. 4), 
hence the NMES sequence is for application to at least two muscles. 

- Claim 29: mechanical motion elements (2, 3, 4) and motors (20, 21 1 22) of D1 
represent a robotic actuator (see also p, 15, I. 2). 

3.2 The features of claims 8-10, 14, 19, 21-25, 28 and 30 represent slight constructional 
changes from the known devices (see documents D1-D4) which come within the scope 
of the customary practice followed by persons skilled in the art, especially as the 



Form PCT/Separate Sheet/409 (Sheet 3) (EPO-April 2005) 



INTERNATIONAL PRELIMINARY 
REPORT ON PATENTABILITY 
(SEPARATE SHEET) 



International application No. 
PCT/IL2005/000442 



advantages thus achieved can readily be foreseen. Moreover, these features concern 
straightforward possibiiities from which the skiiied person wouid select, in accordance 
with circumstances, without the exercise of inventive skill, in order to improve the known 
devices. Consequently, the subject-matter of these claims lacks an inventive step (Article 
33 (3) PCT. 



Re Item VI. 



Certain published documents 



Application No 
Patent No 

WO 2004/050172 



Publication date 
( day/month/year) 

17.06.2004 



Filing ciate 
( day/month/year) 

03,12.2003 



Priority date (valid claim) 
(day/month/year) 

04.12,2003 



This document could become relevant for novelty in further proceedings before the EPCX 



Re Item VII. 



1- Contrary to the requirements of Rule 5.1(a)(ii) PCT, the relevant background art 
disclosed in the documents D1 and D2 is not mentioned in the description, nor are these 
documents identified therein. 



Form PCT/Separate Sheet/409 (Sheet 4) {EPO-Aprif 2005) 



. 2 B/G 2 1 0 g ,. TUE .17:26 FAS 

Wiiiiliii;} . PmISmI 

414/04493 A01 



. : -. l . r i.i- • . , - 



) 



) 



CLAIMS 



1 • Apparatus for muscle activation, comprising: 

at least one electrode CilXS *a*t«*a tr, „ _ 

„ / ^ wuva a neuromuscular stimulation 

(NMES) signal to a body portion (146); 

at le ast one controller (1 24) adapted to provide a NMES signal comprising a 
sequence of stimulation signals to said at least one electrode (1 38); 

a Mechanical motion element (300) coupled to at least one of said body 
portion (146) and a minor body portion (102), wherein said mechanical motion 
element (300) is operatively coupled to said at least one controller (124) and wherein 
W at least one controller (124) control, said NMES signal in conjunction with said 
mechanical motion element (300); and, 

at least one EMG sensor (104) coupled to said mirror body portion (102) 
herein said controller (124) is adapted to generate said NMES signal based on 
sensed EMG signals fiom said at least one EMG sensor (1 04). 

2. Apparatus according to claim 1, wherein said mechanical motion element 
(300) moves said body portion (146). 



3- Apparatus according to claim 1 or claim 2, wherein said mechanical motion 
element (300) measures motion of said body portion (146), which motion f s in 
response.to said NMES sequence. 

4. Apparatus according to any of the preceding claims, wherein said mechanical 
. mouon element (300) guides motion of said body portion (146), which motion is in 
response to said NMES sequence. 

5- Apparatus according to any of the preceding claims, wherein said mechanical 
motion element (300) guides motion of said mirror body portion (102), which NMES 
is generated in response to said motion. 

6- Apparatus according to any of the preceding chums, comprising a programmer 
adapted to program NMES sequences for said electrodes (138). 



33 

|ved at the EPO on Feb 28, 2006 1 5:29:53. Pi AMENDED SHEET 



28/0 2 06 TDE ... 17;:. 26 FAX 

illliliililffl! ilgiilii 

414/04493 A01 

r 

7. Apparatus according to claim 6, wherein said programmer includes a sequence 
optimizer which modifies NMES sequences in response to at least one optimization 
criterion. 



0X0 



S- Apparatus according to claim 7, wherein said optimization criterion comprises 
the ability of a patient. 

9- Apparatus according to claim 7, wherein said optimization criterion comprises 
electrode limitations. 

1 0. Apparatus according to claim 7, wherein said optimization criterion comprises 
a quality of result, as measured by said mechanical motion element (300). 

11. Apparatus according to claim 1, further comprising at least one EMG sensor 
coupi ed to a mixror body portion (102) on a different person for measuring EMG 
signals from the different person. 

12. Apparatus according to claim 1, further comprising at least one EMG sensor 
(148) coupled to said body portion (142) for measuring EMG signals from the body 
portion (142). 

13. Apparatus according to claim 12, wherein said controller (124) generates a 
NMES signal responsive to at least one of an amplitude arid existence of EMG signal 
at a location to which NMES is to be applied. 

! 

14. Apparatus accotding to any of the preceding claims, wherein said controller 
(124) is adapted to generate an indication of which electrodes of said at least one 
electrode to use. 

15. Apparatus according to any of the preceding claims, comprising a memory 
storing therein a plurality of NMES sequences, for at least one daily activity. 

* i 

1 6. Apparatus according to any of the preceding claims, comprising a user input 
for generating a NMES sequence. 

34 

51 2 ved a! the EPO on Fe & 28, 2006 15:29:53. Pz AMENDED SHEET 23/02/2006^ 



) 



Wn 06 TUB 17; 26 FAX 



Oil 



414/04493 AO 1 



17. Apparatus according to any of the preceding claims, wherein said controller 
(124) is adapted to generate a NMES sequence for use for said electrodes based on a 
desired motion of said body portion (146\ 

1 8. Apparatus according to any of the preceding claims, wherein said controller 
(124) is adapted to modify a stored NMES sequence for use for said electrodes based 
on a desired motion of said body portion (146). 

19. Apparatus according to any of the preceding claims, wherein said controller 
(1 24gs;:adapted to compare an actual effect of a NMES sequence and a desired effect 

J r^dr* said sequence and detect at least one deviation. 

20. Apparatus according to any of the preceding claims, wherein said mechanical 
motion element (300) is adapted to measure force applied by said body portion (146) 
in response to said NMES . 

2 1 . Apparatus according to any of the preceding claims, comprising a calibrator 
adapted to calibrate at least one sensor associated with motion of said portion. 

22. Apparatus according to any of the preceding claims, comprising an interactive 
user guide for electrode NMES programming. 

23. .. ^Apparatus according to any of the preceding claims, wherein said electrodes 
are implantable. 

24. Apparatus according to any of the preceding claims, wherein said electrodes 
form part of a prosthesis. 

25. Apparatus according to any of the preceding claims, wherein said electrodes 
are adapted to be worn for the long term. 



) 



35 

stayed at the EPO on Feb 28, 2006 15:29:53. Pz AMENDED SHEET 



28/1)2 06 TOE 17:27 FAI 

414/04493 A01 

r ■ ■ 

26. Apparatus according to any of the preceding claims, wherein said electrodes 
and at least one of said at least one controller (124) are adapted to act independently 
of and removed from said mechanical motion element (300), 

27. Apparatus according to any of the preceding claims, wherein said NMES 
sequence comprises a sequence for application to at least two muscles. 



28. Apparatus according to any 
sequence is at least 20 seconds long, 



NME! 



29. Apparatus according to any of claims wherein said mechanical motion element 
(300) comprises an actuator. 

30. Apparatus according to claim 29, wherein said actuator comprises a robotic 
actuator with at least 3 degrees of motion. 

31- A method of electrode setting for NMES ? comprising: 
applying a NMES sequence to a limb (146); 
measuring motion of the limb (146); 

modifying said NMES sequence responsive to said measured motion; and 
repeating said applying, said measuring and said modifying, using a 
mechanical motion element (300) to at least one of move said limb (146),. resist 
motion of said limb (146) and measure motion of said limb (146). 



36 



4 ved at the EPO on Feb 28, 2006 1 5:29:53. Pz AMENDED SHEET